Yunfeng Zhao Selected Research

Gestational Diabetes (Gestational Diabetes Mellitus)

1/2021	Identification and prioritization of the potent components for combined exposure of multiple persistent organic pollutants associated with gestational diabetes mellitus.
7/2019	Relative Effect Potency Estimates for Dioxin-Like Compounds in Pregnant Women with Gestational Diabetes Mellitus and Blood Glucose Outcomes Based on a Nested Case-control Study.
1/2019	Structure-based investigation on the association between perfluoroalkyl acids exposure and both gestational diabetes mellitus and glucose homeostasis in pregnant women.
10/2018	A nested case-control study of the association between exposure to polybrominated diphenyl ethers and the risk of gestational diabetes mellitus.
7/2018	Association of serum levels of perfluoroalkyl substances with gestational diabetes mellitus and postpartum blood glucose.
1/2018	Non-dioxin-like polychlorinated biphenyls in early pregnancy and risk of gestational diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunfeng Zhao Research Topics

Disease

48	Neoplasms (Cancer) 11/2023 - 09/2002
18	Carcinogenesis 10/2022 - 01/2003
10	Body Weight (Weight, Body) 03/2022 - 10/2005
7	Acute Lung Injury 01/2022 - 01/2011
6	Inflammation (Inflammations) 12/2021 - 01/2009
6	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 01/2018
5	Pulmonary Embolism 11/2023 - 06/2017
5	Pulmonary Edema 01/2022 - 10/2015
5	Melanoma (Melanoma, Malignant) 01/2020 - 05/2008
4	Papillary Thyroid Cancer 11/2023 - 11/2018
4	Hypertension (High Blood Pressure) 06/2023 - 05/2018
4	Lung Neoplasms (Lung Cancer) 12/2021 - 06/2017
4	Skin Neoplasms (Skin Cancer) 01/2018 - 01/2011
4	Breast Neoplasms (Breast Cancer) 06/2015 - 04/2006
3	Lung Injury 01/2022 - 02/2016
3	Hypoxia (Hypoxemia) 10/2019 - 11/2017
2	Type 2 Diabetes Mellitus (MODY) 02/2023 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2022 - 05/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 04/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2017
2	Disease Progression 01/2022 - 01/2011
2	Cholangiocarcinoma 01/2021 - 01/2019
2	Adenocarcinoma of Lung 06/2019 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 06/2010
2	Osteoporosis 09/2015 - 04/2006
2	Ovarian Neoplasms (Ovarian Cancer) 11/2014 - 12/2006
1	Hypersensitivity (Allergy) 02/2024
1	Venous Thromboembolism 01/2024
1	Hemorrhage 01/2024
1	Albuminuria 12/2023

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 10/2022 - 06/2004
11	EnzymesIBA 10/2022 - 06/2004
9	AntioxidantsIBA 04/2022 - 06/2004
8	Uncoupling Protein 2IBA 01/2020 - 01/2013
7	CarcinogensIBA 01/2015 - 01/2009
6	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 09/2011
6	Superoxide DismutaseIBA 04/2014 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
5	LipopolysaccharidesIBA 01/2022 - 01/2015
5	AntibodiesIBA 09/2015 - 01/2002
4	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2016 - 01/2003
4	Pyruvate KinaseIBA 01/2015 - 09/2011
3	ORALIT (ORS)IBA 12/2023 - 05/2018
3	Blood Glucose (Blood Sugar)IBA 02/2023 - 07/2018
3	DioxinsIBA 01/2021 - 01/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 05/2005
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 07/2014
3	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2019 - 10/2005
3	NF-kappa B (NF-kB)IBA 10/2015 - 10/2005
3	Monoclonal AntibodiesIBA 06/2015 - 09/2002
3	shikoninIBA 01/2015 - 01/2014
3	ProtandimIBA 01/2011 - 01/2009
2	AnticoagulantsIBA 01/2024 - 01/2023
2	CarbonIBA 11/2023 - 11/2014
2	fibrin fragment D (D-dimer)IBA 11/2023 - 06/2017
2	Endocrine DisruptorsIBA 11/2023 - 01/2023
2	bis(4-hydroxyphenyl)sulfoneIBA 01/2023 - 03/2022
2	tyramine-deoxysorbitolIBA 03/2022 - 03/2022
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 12/2021 - 02/2020
2	Halogenated Diphenyl EthersIBA 01/2021 - 10/2018
2	AcidsIBA 01/2021 - 01/2019
2	Polychlorinated Biphenyls (PCBs)IBA 01/2021 - 01/2018
2	Indicators and Reagents (Reagents)IBA 02/2020 - 05/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2019
2	genipinIBA 01/2020 - 01/2019
2	Gemcitabine FDA Link 01/2020 - 01/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2019 - 04/2006
2	withaferin AIBA 10/2019 - 11/2016
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2019 - 08/2012
2	Okadaic AcidIBA 06/2019 - 01/2014
2	CeramidesIBA 01/2019 - 11/2014
2	RNA Precursors (Precursor, mRNA)IBA 01/2019 - 11/2014
2	Mutant Proteins (Protein, Mutant)IBA 01/2019 - 11/2014
2	LipidsIBA 01/2018 - 10/2017
2	Activating Transcription Factor 3IBA 12/2017 - 10/2017
2	AnionsIBA 11/2017 - 01/2017
2	LigandsIBA 06/2017 - 01/2011
2	CytokinesIBA 02/2016 - 09/2015
2	Small Interfering RNA (siRNA)IBA 02/2016 - 10/2010
2	Interleukin-6 (Interleukin 6)IBA 10/2015 - 01/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2015 - 04/2006
2	Mitochondrial Uncoupling ProteinsIBA 06/2015 - 01/2011
2	Phosphotransferases (Kinase)IBA 06/2015 - 01/2014
2	Free RadicalsIBA 06/2015 - 05/2008
2	Protein Isoforms (Isoforms)IBA 01/2015 - 09/2011
2	Tamoxifen FDA LinkGeneric 04/2014 - 04/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2011 - 06/2010
2	Antineoplastic Agents (Antineoplastics)IBA 06/2010 - 04/2006
2	CarbohydratesIBA 02/2007 - 09/2002
2	Peptides (Polypeptides)IBA 02/2007 - 09/2002
2	Proteasome InhibitorsIBA 12/2006 - 10/2005
2	Acetates (Acetic Acid Esters)FDA Link 08/2006 - 05/2005
1	Phosphates (Orthophosphate)IBA 02/2024
1	Ethylene Oxide (Oxirane)IBA 12/2023
1	Hemoglobins (Hemoglobin)IBA 12/2023

Therapy/Procedure

18	Therapeutics 11/2023 - 10/2005
3	Immunotherapy 01/2021 - 01/2013
3	Drug Therapy (Chemotherapy) 01/2021 - 12/2006
3	Chemoprevention 01/2015 - 01/2009
2	Radiotherapy 01/2021 - 10/2005